文献速递淋巴瘤

SLAMF受体通过招募抑制素-2负向调控慢性淋巴细胞白血病中的B细胞受体信号

SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
PubMed 文献 · Leukemia · 2020-08-21

研究发现SLAMF受体相关信号高的慢性淋巴细胞白血病(CLL)患者临床病程惰性。SLAMF1/SLAMF7低表达患者原代NK细胞脱颗粒能力显著下降。在IGHV突变CLL细胞模型中过表达SLAMF1或SLAMF7可减少增殖并损伤BCR连接反应,双敲除则相反;机制上SLAMF1/SLAMF7通过招募抑制素-2(PHB2)拮抗BCR通路。

要点

  • SLAMF受体相关信号高的CLL患者临床病程惰性。
  • SLAMF1/SLAMF7低表达CLL患者NK细胞脱颗粒能力显著下降。
  • SLAMF1/SLAMF7通过招募PHB2负向调控IGHV突变CLL的BCR信号。

核心结论

  • SLAMF受体是BCR信号轴的重要调节因子,可能通过干扰NK细胞改善CLL的免疫控制。

研究设计与样本

  • 研究纳入SLAMF受体相关信号高的CLL患者亚群,并在IGHV突变CLL细胞模型中进行过表达和敲除实验。

主要发现

  • SLAMF1和SLAMF7低表达的CLL患者原代NK细胞脱颗粒能力显著下降。
  • 在IGHV突变CLL细胞模型中过表达SLAMF1或SLAMF7导致增殖减少且对BCR连接反应受损。
  • 同时敲除SLAMF1和SLAMF7产生相反效应,并增加对BCR通路组分抑制的敏感性。
  • SLAMF1和SLAMF7通过招募PHB2 impair其在下游信号转导中的作用来介导BCR通路拮抗效应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We identified a subset of Chronic Lymphocytic Leukemia (CLL) patients with high Signaling Lymphocytic Activation Molecule Family (SLAMF) receptor-related signaling that showed an indolent clinical course. Since SLAMF receptors play a role in NK cell biology, we reasoned that these receptors may impact NK cell-mediated CLL immunity. Indeed, our experiments showed significantly decreased degranulation capacity of primary NK cells from CLL patients expressing low levels of SLAMF1 and SLAMF7. Since the SLAMFlow signature was strongly associated with an unmutated CLL immunoglobulin heavy chain (IGHV) status in large datasets, we investigated the impact of SLAMF1 and SLAMF7 on the B cell receptor (BCR) signaling axis. Overexpression of SLAMF1 or SLAMF7 in IGHV mutated CLL cell models resulted in reduced proliferation and impaired responses to BCR ligation, whereas the knockout of both receptors showed opposing effects and increased sensitivity toward inhibition of components of the BCR pathway. Detailed molecular analyzes showed that SLAMF1 and SLAMF7 receptors mediate their BCR pathway antagonistic effects via recruitment of prohibitin-2 (PHB2) thereby impairing its role in signal transduction downstream the IGHV-mutant IgM-BCR. Together, our data indicate that SLAMF receptors are important modulators of the BCR signaling axis and may improve immune control in CLL by interference with NK cells.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. von Wenserski L, Schultheiß C, Bolz S, et al. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2. Leukemia. 2020. PMID: 32826957. doi:10.1038/s41375-020-01025-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。